Ventus Therapeutics

Ventus Therapeutics

  • Founded: 2019
  • Location: Waltham, MA
  • Employee range: 11 - 50
  • Clinical stage: Clin0
  • Therapy area: Immunology, Rheumatology
  • Drug types: IMM, RHU, DRM, NEU, GI, HEP, NPH, CVV
  • Lead product: VENT-03
  • Product link:
  • Funding: $140M C Feb 2022; $100M Apr 2021; $60M A May 2020
  • Investors: Versant Ventures

job board

Short description:

Small Molecules targeting proteins in the inflammasome and nucleic acid sensing signaling pathways

Drug notes:

VENT-02 Clin1 neuro; VENT-01 Clin0 renal, cardiovascular, hepatic; VENT-05 RD undisclosed; VENT-04 RD various

Long description:

Contact us to add description:


Ventus Therapeutics
Principal Investigator, Translational Science (Bio...
Waltham, Massachusetts, Stati Uniti d'America|18 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy